Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BAY 3018250

Next Previous
Drug Profile

BAY 3018250

Alternative Names: Anti-a2AP; BAY-3018250

Latest Information Update: 28 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer
  • Class Antithrombotics; Monoclonal antibodies; Vascular disorder therapies
  • Mechanism of Action Antiplasmin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Thrombosis
  • Phase I Pulmonary embolism; Vascular disorders
  • No development reported Ischaemic stroke

Most Recent Events

  • 28 Dec 2025 No recent reports of development identified for phase-I development in Ischaemic stroke(In volunteers) in Germany (Parenteral)
  • 02 Dec 2025 Bayer completes a phase II trial in Thrombosis in Turkey, Spain, Slovakia, Netherlands, Italy, Hungary, Czech Republic, Greece, Canada, Bulgaria, Germany, France, Belgium (Parenteral) (NCT06149520)
  • 10 Feb 2025 Bayer completes a phase I trial Thrombosis (in volunteers) in China (Parenteral) (NCT06619483)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top